The airway clearance devices for cystic fibrosis market size has grown strongly in recent years. It will grow from $2.73 billion in 2025 to $2.89 billion in 2026 at a compound annual growth rate (CAGR) of 5.6%. The growth in the historic period can be attributed to rising prevalence of cystic fibrosis diagnoses, improved survival rates among cf patients, increased availability of respiratory therapy devices, expansion of home healthcare services, growing awareness of airway clearance therapies.
The airway clearance devices for cystic fibrosis market size is expected to see strong growth in the next few years. It will grow to $3.58 billion in 2030 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to increasing focus on personalized respiratory care, rising adoption of connected respiratory devices, expansion of telehealth-supported cf management, growing demand for lightweight and portable systems, increasing investments in respiratory device innovation. Major trends in the forecast period include increasing adoption of portable airway clearance devices, growing demand for home-based respiratory care solutions, rising use of wearable chest oscillation systems, expansion of pediatric-specific device designs, enhanced focus on patient comfort and compliance.
The growing incidence of lung disorders is anticipated to drive the expansion of the airway clearance devices market for cystic fibrosis in the near future. Lung disorders are conditions that result in the excessive production of mucus and impaired lung function, leading to an increasing demand for effective solutions to clear airways and enhance respiratory health. This rise in lung disorders can be attributed to various interconnected factors, including increased air pollution, smoking, and tobacco consumption, all of which significantly contribute to respiratory diseases and long-term lung damage. Airway clearance devices such as high-frequency chest wall oscillation (HFCWO) vests, positive expiratory pressure (PEP) devices, and oscillatory PEP devices play a crucial role in breaking up and clearing thick mucus from the airways, which is especially beneficial for cystic fibrosis patients who suffer from thick and sticky mucus that causes chronic lung infections and breathing problems. For example, in March 2024, the Centers for Disease Control and Prevention (CDC), a US-based government agency, reported a rise in tuberculosis cases, from 8,320 in 2022 to 9,615 in 2023, reflecting an increase of 1,295 cases. Thus, the growing prevalence of lung disorders is expected to drive the market for airway clearance devices in cystic fibrosis.
Major companies operating in the airway clearance devices for cystic fibrosis market are concentrating on technological innovations such as high-frequency chest wall oscillation technology to improve the efficiency of mucus clearance, enhance patient comfort, shorten treatment duration, and offer non-invasive, home-based treatment options, ultimately contributing to improved clinical outcomes and quality of life for individuals with cystic fibrosis. High-frequency chest wall oscillation technology is a therapeutic approach that employs rapid air pulses to generate vibrations across the chest wall, facilitating the loosening and movement of mucus for easier elimination from the lungs. For example, in September 2024, Baxter International Inc., a US-based healthcare company, introduced its next-generation airway clearance system, the Vest Advanced Pulmonary Experience (APX) System, at the North American Cystic Fibrosis Conference. The Vest APX System maintains the proven airflow technology of its predecessor while integrating enhanced comfort and patient-centric features based on input from clinicians and patients. It is intended to support daily therapy for both adults and children with certain chronic lung conditions and retained secretions.
In September 2023, Inogen Inc., a US-based medical technology company, acquired Physio-Assist SAS for an undisclosed amount. Through this acquisition, Inogen intends to expand its respiratory care portfolio and address the growing and underserved airway clearance market, particularly with the Simeox device for bronchiectasis and other chronic respiratory conditions. Physio-Assist SAS, based in France, specializes in airway clearance and mucus management devices.
Major companies operating in the airway clearance devices for cystic fibrosis market are Koninklijke Philips N.V., Baxter International Inc., ICU Medical Inc., Vyaire Medical Inc., Tactile Systems Technology Inc., RespirTech, Mercury Medical Inc., Electromed Inc., Vitality Medical Inc., Monaghan Medical Corporation, Pulmodyne Inc., PARI GmbH, Flexicare Limited, D.R. Burton Healthcare Limited, Intersurgical Ltd., Clement Clarke International Ltd., Thayer Medical Inc., AirPhysio, VORTRAN Medical Technology Inc., Med Systems Inc., Wave Healthcare.
North America was the largest region in the airway clearance devices for cystic fibrosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the airway clearance devices for cystic fibrosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the airway clearance devices for cystic fibrosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the airway clearance devices for cystic fibrosis market by increasing costs of imported medical-grade plastics, electronic components, sensors, pneumatic systems, and wearable device modules. Healthcare providers in North America and Europe are most affected due to reliance on imported specialized components, while Asia-Pacific faces pricing pressure on device manufacturing and exports. These tariffs are increasing device costs and reimbursement challenges for patients. However, they are also encouraging local manufacturing, regional sourcing of components, and innovation in cost-efficient airway clearance technologies.
The airway clearance devices for cystic fibrosis market research report is one of a series of new reports that provides airway clearance devices for cystic fibrosis market statistics, including airway clearance devices for cystic fibrosis industry global market size, regional shares, competitors with a airway clearance devices for cystic fibrosis market share, detailed airway clearance devices for cystic fibrosis market segments, market trends and opportunities, and any further data you may need to thrive in the airway clearance devices for cystic fibrosis industry. This airway clearance devices for cystic fibrosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Airway clearance devices for cystic fibrosis are medical instruments designed to assist in clearing mucus from the lungs, thereby improving respiratory function and reducing the likelihood of lung infections. These devices are primarily used to manage respiratory symptoms, boost lung function, and enhance the quality of life for individuals with cystic fibrosis or other chronic respiratory conditions.
The key types of airway clearance devices for cystic fibrosis include vest systems, intrapulmonary percussive ventilators (IPV), positive expiratory pressure (PEP) devices, high-frequency chest wall oscillation (HFCWO) devices, and other related devices. Vest systems are wearable devices that use rapid air pulses to help clear mucus from the lungs. These devices are used by both adult and pediatric patients with cystic fibrosis. They are commonly found in hospitals, clinics, home healthcare settings, and other healthcare environments.
The airway clearance devices for cystic fibrosis market consists of sales of incentive spirometers, manual chest physiotherapy (CPT) devices and nebulizers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The airway clearance devices for cystic fibrosis market size is expected to see strong growth in the next few years. It will grow to $3.58 billion in 2030 at a compound annual growth rate (CAGR) of 5.5%. The growth in the forecast period can be attributed to increasing focus on personalized respiratory care, rising adoption of connected respiratory devices, expansion of telehealth-supported cf management, growing demand for lightweight and portable systems, increasing investments in respiratory device innovation. Major trends in the forecast period include increasing adoption of portable airway clearance devices, growing demand for home-based respiratory care solutions, rising use of wearable chest oscillation systems, expansion of pediatric-specific device designs, enhanced focus on patient comfort and compliance.
The growing incidence of lung disorders is anticipated to drive the expansion of the airway clearance devices market for cystic fibrosis in the near future. Lung disorders are conditions that result in the excessive production of mucus and impaired lung function, leading to an increasing demand for effective solutions to clear airways and enhance respiratory health. This rise in lung disorders can be attributed to various interconnected factors, including increased air pollution, smoking, and tobacco consumption, all of which significantly contribute to respiratory diseases and long-term lung damage. Airway clearance devices such as high-frequency chest wall oscillation (HFCWO) vests, positive expiratory pressure (PEP) devices, and oscillatory PEP devices play a crucial role in breaking up and clearing thick mucus from the airways, which is especially beneficial for cystic fibrosis patients who suffer from thick and sticky mucus that causes chronic lung infections and breathing problems. For example, in March 2024, the Centers for Disease Control and Prevention (CDC), a US-based government agency, reported a rise in tuberculosis cases, from 8,320 in 2022 to 9,615 in 2023, reflecting an increase of 1,295 cases. Thus, the growing prevalence of lung disorders is expected to drive the market for airway clearance devices in cystic fibrosis.
Major companies operating in the airway clearance devices for cystic fibrosis market are concentrating on technological innovations such as high-frequency chest wall oscillation technology to improve the efficiency of mucus clearance, enhance patient comfort, shorten treatment duration, and offer non-invasive, home-based treatment options, ultimately contributing to improved clinical outcomes and quality of life for individuals with cystic fibrosis. High-frequency chest wall oscillation technology is a therapeutic approach that employs rapid air pulses to generate vibrations across the chest wall, facilitating the loosening and movement of mucus for easier elimination from the lungs. For example, in September 2024, Baxter International Inc., a US-based healthcare company, introduced its next-generation airway clearance system, the Vest Advanced Pulmonary Experience (APX) System, at the North American Cystic Fibrosis Conference. The Vest APX System maintains the proven airflow technology of its predecessor while integrating enhanced comfort and patient-centric features based on input from clinicians and patients. It is intended to support daily therapy for both adults and children with certain chronic lung conditions and retained secretions.
In September 2023, Inogen Inc., a US-based medical technology company, acquired Physio-Assist SAS for an undisclosed amount. Through this acquisition, Inogen intends to expand its respiratory care portfolio and address the growing and underserved airway clearance market, particularly with the Simeox device for bronchiectasis and other chronic respiratory conditions. Physio-Assist SAS, based in France, specializes in airway clearance and mucus management devices.
Major companies operating in the airway clearance devices for cystic fibrosis market are Koninklijke Philips N.V., Baxter International Inc., ICU Medical Inc., Vyaire Medical Inc., Tactile Systems Technology Inc., RespirTech, Mercury Medical Inc., Electromed Inc., Vitality Medical Inc., Monaghan Medical Corporation, Pulmodyne Inc., PARI GmbH, Flexicare Limited, D.R. Burton Healthcare Limited, Intersurgical Ltd., Clement Clarke International Ltd., Thayer Medical Inc., AirPhysio, VORTRAN Medical Technology Inc., Med Systems Inc., Wave Healthcare.
North America was the largest region in the airway clearance devices for cystic fibrosis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the airway clearance devices for cystic fibrosis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the airway clearance devices for cystic fibrosis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the airway clearance devices for cystic fibrosis market by increasing costs of imported medical-grade plastics, electronic components, sensors, pneumatic systems, and wearable device modules. Healthcare providers in North America and Europe are most affected due to reliance on imported specialized components, while Asia-Pacific faces pricing pressure on device manufacturing and exports. These tariffs are increasing device costs and reimbursement challenges for patients. However, they are also encouraging local manufacturing, regional sourcing of components, and innovation in cost-efficient airway clearance technologies.
The airway clearance devices for cystic fibrosis market research report is one of a series of new reports that provides airway clearance devices for cystic fibrosis market statistics, including airway clearance devices for cystic fibrosis industry global market size, regional shares, competitors with a airway clearance devices for cystic fibrosis market share, detailed airway clearance devices for cystic fibrosis market segments, market trends and opportunities, and any further data you may need to thrive in the airway clearance devices for cystic fibrosis industry. This airway clearance devices for cystic fibrosis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Airway clearance devices for cystic fibrosis are medical instruments designed to assist in clearing mucus from the lungs, thereby improving respiratory function and reducing the likelihood of lung infections. These devices are primarily used to manage respiratory symptoms, boost lung function, and enhance the quality of life for individuals with cystic fibrosis or other chronic respiratory conditions.
The key types of airway clearance devices for cystic fibrosis include vest systems, intrapulmonary percussive ventilators (IPV), positive expiratory pressure (PEP) devices, high-frequency chest wall oscillation (HFCWO) devices, and other related devices. Vest systems are wearable devices that use rapid air pulses to help clear mucus from the lungs. These devices are used by both adult and pediatric patients with cystic fibrosis. They are commonly found in hospitals, clinics, home healthcare settings, and other healthcare environments.
The airway clearance devices for cystic fibrosis market consists of sales of incentive spirometers, manual chest physiotherapy (CPT) devices and nebulizers. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Airway Clearance Devices for Cystic Fibrosis Market Characteristics
3. Airway Clearance Devices for Cystic Fibrosis Market Supply Chain Analysis
4. Global Airway Clearance Devices for Cystic Fibrosis Market Trends and Strategies
5. Airway Clearance Devices for Cystic Fibrosis Market Analysis of End Use Industries
7. Global Airway Clearance Devices for Cystic Fibrosis Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Airway Clearance Devices for Cystic Fibrosis Total Addressable Market (TAM) Analysis for the Market
9. Airway Clearance Devices for Cystic Fibrosis Market Segmentation
10. Airway Clearance Devices for Cystic Fibrosis Market Regional and Country Analysis
11. Asia-Pacific Airway Clearance Devices for Cystic Fibrosis Market
12. China Airway Clearance Devices for Cystic Fibrosis Market
13. India Airway Clearance Devices for Cystic Fibrosis Market
14. Japan Airway Clearance Devices for Cystic Fibrosis Market
15. Australia Airway Clearance Devices for Cystic Fibrosis Market
16. Indonesia Airway Clearance Devices for Cystic Fibrosis Market
17. South Korea Airway Clearance Devices for Cystic Fibrosis Market
18. Taiwan Airway Clearance Devices for Cystic Fibrosis Market
19. South East Asia Airway Clearance Devices for Cystic Fibrosis Market
20. Western Europe Airway Clearance Devices for Cystic Fibrosis Market
21. UK Airway Clearance Devices for Cystic Fibrosis Market
22. Germany Airway Clearance Devices for Cystic Fibrosis Market
23. France Airway Clearance Devices for Cystic Fibrosis Market
24. Italy Airway Clearance Devices for Cystic Fibrosis Market
25. Spain Airway Clearance Devices for Cystic Fibrosis Market
26. Eastern Europe Airway Clearance Devices for Cystic Fibrosis Market
27. Russia Airway Clearance Devices for Cystic Fibrosis Market
28. North America Airway Clearance Devices for Cystic Fibrosis Market
29. USA Airway Clearance Devices for Cystic Fibrosis Market
30. Canada Airway Clearance Devices for Cystic Fibrosis Market
31. South America Airway Clearance Devices for Cystic Fibrosis Market
32. Brazil Airway Clearance Devices for Cystic Fibrosis Market
33. Middle East Airway Clearance Devices for Cystic Fibrosis Market
34. Africa Airway Clearance Devices for Cystic Fibrosis Market
36. Airway Clearance Devices for Cystic Fibrosis Market Competitive Landscape and Company Profiles
37. Airway Clearance Devices for Cystic Fibrosis Market Other Major and Innovative Companies
40. Airway Clearance Devices for Cystic Fibrosis Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Airway Clearance Devices For Cystic Fibrosis Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses airway clearance devices for cystic fibrosis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for airway clearance devices for cystic fibrosis? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The airway clearance devices for cystic fibrosis market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Device Type: Vest Systems; Intrapulmonary Percussive Ventilators (IPV); Positive Expiratory Pressure (PEP) Devices; High-Frequency Chest Wall Oscillation (HFCWO) Devices; Other Airway Clearance Devices2) By Patient Type: Adults With Cystic Fibrosis; Pediatric Patients With Cystic Fibrosis
3) By End User: Hospitals And Clinics; Home Healthcare Settings; Other End Users
Subsegments:
1) By Vest Systems: Pneumatic Vest Systems; Electrical Vest Systems2) By Intrapulmonary Percussive Ventilators (IPV): Manual IPV Devices; Automatic IPV Devices
3) By Positive Expiratory Pressure (PEP) Devices: Single-Use PEP Devices; Reusable PEP Devices
4) By High-Frequency Chest Wall Oscillation (HFCWO) Devices: Portable HFCWO Devices; Hospital-Grade HFCWO Devices
5) By Other Airway Clearance Devices: Oscillating Positive Expiratory Pressure (OPEP) Devices; Mechanical Insufflation-Exsufflation Devices
Companies Mentioned: Koninklijke Philips N.V.; Baxter International Inc.; ICU Medical Inc.; Vyaire Medical Inc.; Tactile Systems Technology Inc.; RespirTech; Mercury Medical Inc.; Electromed Inc.; Vitality Medical Inc.; Monaghan Medical Corporation; Pulmodyne Inc.; PARI GmbH; Flexicare Limited; D.R. Burton Healthcare Limited; Intersurgical Ltd.; Clement Clarke International Ltd.; Thayer Medical Inc.; AirPhysio; VORTRAN Medical Technology Inc.; Med Systems Inc.; Wave Healthcare
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Airway Clearance Devices for Cystic Fibrosis market report include:- Koninklijke Philips N.V.
- Baxter International Inc.
- ICU Medical Inc.
- Vyaire Medical Inc.
- Tactile Systems Technology Inc.
- RespirTech
- Mercury Medical Inc.
- Electromed Inc.
- Vitality Medical Inc.
- Monaghan Medical Corporation
- Pulmodyne Inc.
- PARI GmbH
- Flexicare Limited
- D.R. Burton Healthcare Limited
- Intersurgical Ltd.
- Clement Clarke International Ltd.
- Thayer Medical Inc.
- AirPhysio
- VORTRAN Medical Technology Inc.
- Med Systems Inc.
- Wave Healthcare
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 2.89 Billion |
| Forecasted Market Value ( USD | $ 3.58 Billion |
| Compound Annual Growth Rate | 5.5% |
| Regions Covered | Global |
| No. of Companies Mentioned | 22 |
